nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abiraterone acetate: redefining hormone treatment for advanced prostate cancer
|
Pezaro, Carmel J. |
|
2012 |
17 |
5-6 |
p. 221-226 6 p. |
artikel |
2 |
Cancer cell senescence: a new frontier in drug development
|
Cairney, Claire J. |
|
2012 |
17 |
5-6 |
p. 269-276 8 p. |
artikel |
3 |
Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective
|
Williams, Robert J. |
|
2012 |
17 |
5-6 |
p. 185-187 3 p. |
artikel |
4 |
Combining imaging and pathway profiling: an alternative approach to cancer drug discovery
|
Carragher, Neil O. |
|
2012 |
17 |
5-6 |
p. 203-214 12 p. |
artikel |
5 |
Contents page 2
|
|
|
2012 |
17 |
5-6 |
p. iii- 1 p. |
artikel |
6 |
Contents page 1
|
|
|
2012 |
17 |
5-6 |
p. i- 1 p. |
artikel |
7 |
Exploiting genetic complexity in cancer to improve therapeutic strategies
|
Garnett, Mathew J. |
|
2012 |
17 |
5-6 |
p. 188-193 6 p. |
artikel |
8 |
HSP90 inhibition: two-pronged exploitation of cancer dependencies
|
Travers, Jon |
|
2012 |
17 |
5-6 |
p. 242-252 11 p. |
artikel |
9 |
New regulatory framework for cancer drug development
|
Jones, Paul S. |
|
2012 |
17 |
5-6 |
p. 227-231 5 p. |
artikel |
10 |
Pathways and targets—opposite approaches to success?
|
Blundy, Keith |
|
2012 |
17 |
5-6 |
p. 183-184 2 p. |
artikel |
11 |
Predictive in vivo animal models and translation to clinical trials
|
Cook, Natalie |
|
2012 |
17 |
5-6 |
p. 253-260 8 p. |
artikel |
12 |
Stratified medicine for cancer therapy
|
Shaw, Emily C. |
|
2012 |
17 |
5-6 |
p. 261-268 8 p. |
artikel |
13 |
Targeting cancer metabolism – aiming at a tumour's sweet-spot
|
Jones, Neil P. |
|
2012 |
17 |
5-6 |
p. 232-241 10 p. |
artikel |
14 |
Targeting the S and G2 checkpoint to treat cancer
|
Chen, Tao |
|
2012 |
17 |
5-6 |
p. 194-202 9 p. |
artikel |
15 |
Virotherapy – cancer targeted pharmacology
|
Tedcastle, Alison |
|
2012 |
17 |
5-6 |
p. 215-220 6 p. |
artikel |